Neuroimmunology – Nervous System and Immune System

What Is Neuroimmunology?

Neuroimmunology is an interdisciplinary field of medicine and the life sciences that investigates the complex interactions between the nervous system and the immune system. It brings together insights from neurology, immunology, and molecular biology to understand how these two systems communicate, influence one another, and jointly contribute to the development or progression of disease.

For a long time, the brain was considered an immune-privileged organ – largely shielded from the immune system. However, modern research has demonstrated that immune cells and signaling molecules (known as cytokines) actively interact with the nervous system and play a critical role in inflammation, tissue repair, and disease processes in the brain.

Fundamentals of the Nervous System – Immune System Interaction

The nervous system and the immune system communicate through several distinct pathways:

• Neurotransmitters and neuropeptides: Signaling molecules such as dopamine, serotonin, and substance P can directly influence immune cells and regulate their activity.
• Cytokines: These immune messengers (e.g., interleukin-1, interleukin-6, tumor necrosis factor-alpha) can cross the blood-brain barrier and affect nerve cells as well as glial cells.
• Microglia: These specialized immune cells of the central nervous system (CNS) are continuously active and carry out immune defense, inflammation regulation, and tissue maintenance in the brain.
• Blood-brain barrier: This barrier regulates the exchange of molecules and cells between the bloodstream and the brain. During inflammation, it can become more permeable, allowing immune cells to enter the CNS.

Clinical Relevance and Disease Patterns

Over recent decades, neuroimmunology has significantly advanced the understanding of the causes and mechanisms of many neurological and psychiatric conditions. Key neuroimmunological diseases include:

Multiple Sclerosis (MS)

Multiple sclerosis is one of the most well-known neuroimmunological diseases. In MS, the immune system mistakenly attacks the myelin sheaths surrounding nerve fibers in the CNS (an autoimmune reaction), leading to inflammation, demyelination, and neurological dysfunction.

Autoimmune Encephalitis

In autoimmune encephalitis, antibodies target specific proteins in the brain, such as NMDA receptors (anti-NMDA receptor encephalitis). This can cause severe psychiatric and neurological symptoms.

Guillain-Barre Syndrome

Guillain-Barre syndrome is an acute disorder of the peripheral nervous system in which the immune system attacks nerve roots, potentially leading to ascending paralysis.

Neuromyelitis Optica Spectrum Disorders (NMOSD)

These conditions primarily affect the optic nerves and spinal cord and are triggered by antibodies against aquaporin-4 or MOG (myelin oligodendrocyte glycoprotein).

Neurological Involvement in Systemic Autoimmune Diseases

Diseases such as systemic lupus erythematosus (SLE) or Sjogren syndrome can involve the nervous system and produce neuroimmunological symptoms.

Neuroinflammation in Neurodegenerative Diseases

Current research increasingly shows that chronic inflammatory processes in the brain – referred to as neuroinflammation – also play a significant role in conditions such as Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis (ALS).

Diagnosis of Neuroimmunological Diseases

Diagnosing neuroimmunological conditions requires a broad range of investigative methods:

• Cerebrospinal fluid (CSF) analysis (lumbar puncture): Examination of cerebrospinal fluid for signs of inflammation, antibodies, and other biomarkers.
• Magnetic resonance imaging (MRI): Imaging to visualize areas of inflammation, demyelination, or structural changes in the brain and spinal cord.
• Antibody testing: Detection of specific autoantibodies in blood or CSF (e.g., aquaporin-4 antibodies, MOG antibodies, NMDA receptor antibodies).
• Electrophysiological studies: Such as evoked potentials to assess nerve conduction velocity.
• Neuropsychological testing: To evaluate cognitive and psychiatric symptoms.

Treatment of Neuroimmunological Diseases

Treatment depends on the specific condition and generally involves immunomodulatory or immunosuppressive strategies:

• Corticosteroids: Frequently used during acute relapses to rapidly reduce inflammation.
• Immunosuppressants: Medications such as azathioprine, mycophenolate mofetil, or methotrexate suppress the immune response over the long term.
• Biologics and monoclonal antibodies: Targeted therapies such as natalizumab, ocrelizumab, or rituximab intervene specifically in immune processes.
• Plasmapheresis and intravenous immunoglobulins: In severe autoimmune reactions, these approaches can remove or neutralize harmful antibodies from the blood.
• Symptomatic therapy: Physiotherapy, occupational therapy, speech therapy, and psychological support to improve quality of life.

Current Research and Future Perspectives

Neuroimmunology is one of the fastest-growing fields in modern medicine. New findings on the role of the gut-brain axis, the glymphatic system (the brain's waste-clearance network), and the genetic basis of neuroimmunological diseases are opening promising avenues for new therapies. The ultimate goal of research is to develop more targeted, better-tolerated treatments that sustainably improve the quality of life for those affected.

References

1. Ransohoff, R.M. et al. - Neuroinflammation: Ways in which the immune and nervous systems interact. Journal of Clinical Investigation, 2012.
2. Compston, A. & Coles, A. - Multiple sclerosis. The Lancet, 2008; 372(9648): 1502-1517.
3. National Institute of Neurological Disorders and Stroke (NINDS) - Neuroimmunology Research Overview, 2023. Available at: https://www.ninds.nih.gov